{"id":12350,"date":"2024-10-11T23:00:33","date_gmt":"2024-10-11T21:00:33","guid":{"rendered":"https:\/\/valintermed.com\/?p=12350"},"modified":"2024-10-11T23:00:33","modified_gmt":"2024-10-11T21:00:33","slug":"osteoglobionicheskaya-displaziya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/osteoglobionicheskaia-dysplasia\/","title":{"rendered":"Osteoglobinic dysplasia"},"content":{"rendered":"
<\/div>\n

Osteoglobinic dysplasia (OGD) is a rare hereditary disease characterized by abnormal bone development, leading to skeletal deformities and compromised strength. The main microscopic changes are associated with a lack of bone matrix and impaired mineralization, which in turn leads to increased bone fragility and susceptibility to fractures. The disease often manifests itself in childhood, but may also remain unrecognized until adulthood. Clinical manifestations vary from minor dysplasia to severe forms accompanied by multiple fractures and patient disability. Treatment of the disease often requires an interdisciplinary approach, as it is associated with several specific clinical and laboratory diagnostics, as well as the need for continuous monitoring of the patient's condition.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n